Jump to main content

Menu

Login

Search

  • Ensuring Supply
    • Overview: Ensuring Supply
    • What Blood Products are Supplied - National Product Price List
    • Supply Planning and Management
    • Changes to National Product Price List
    • Contracts with Suppliers
    • Supply to Australians Overseas
    • Risk Management
    • Blood Product Managment
      • Wastage
      • 10 Tips to Help Manage your Blood Product Inventory
      • Group O negative red blood cell management
      • Managing Blood and Blood Product Inventory Guidelines for Australian Health Providers
        • Module 1: Managing Blood and Blood Product Transfers
        • Module 2: Ig Inventory Management Guidelines
    • Transition of Australia's Domestic Plasma Products: What you need to do to start preparing
    • Australian Health Provider Blood and Blood Products Charter
  • Best Practice
  • Blood Systems
  • Data & Research
  • About Blood
  • Publications & Tools
  • Home
  • News
  • Contact Us

Search

Home
  • Home
  • News
  • Contact Us

BloodPortal Sign in

Search

  • Ensuring Supply
    • Overview: Ensuring Supply
    • What Blood Products are Supplied - National Product Price List
    • Supply Planning and Management
    • Changes to National Product Price List
    • Contracts with Suppliers
      • Customer Feedback on Commercial Supply Contracts
      • Fresh Blood Product Procurement
      • Imported Products
      • Plasma and Recombinant Product Procurement
      • Red Cell Diagnostic Reagents Product Procurement
    • Supply to Australians Overseas
    • Risk Management
      • National Blood Supply Contingency Plan
      • National Managed Fund
      • Supply Risk Management Measures
    • Blood Product Managment
      • Wastage
        • Stop the Waste!
      • 10 Tips to Help Manage your Blood Product Inventory
      • Group O negative red blood cell management
      • Managing Blood and Blood Product Inventory Guidelines for Australian Health Providers
        • Module 1: Managing Blood and Blood Product Transfers
        • Module 2: Ig Inventory Management Guidelines
    • Transition of Australia's Domestic Plasma Products: What you need to do to start preparing
    • Australian Health Provider Blood and Blood Products Charter
  • Best Practice
    • National Standard
      • Standard 7 and the Patient Blood Management (PBM) Guidelines
      • Pathology Service Provider Obligations Under NSQHS Standard 7 – Blood and Blood Products
    • Case Studies
      • Pathology Queensland Case Study
        • Royal Brisbane and Women’s Hospital
        • Redcliffe Hospital
        • Toowoomba Hospital
        • Townsville Hospital
      • NSW Health Pathology – North (Hunter) Case Study
        • 1. Strong Inventory Management
        • 2. Speed of Release
        • 3. Involved Haematologists
        • 4. Age of Blood
      • SAN Pathology Case Study
      • BloodMove Project Case Study
        • 1. Aims
        • 2. Staffing and governance
        • 3. Implementation and hub-spoke arrangements
        • 4. BloodMove features and strengths
        • 5. The future
        • 6. BloodMove Achievements Since the 2013 Case Study
      • BloodMove Platelets - Case Study
        • Introduction, Background and Aim
        • Implementation
        • Results
        • Future Initiatives
      • Burnside War Memorial Hospital Case Study
        • Who are Burnside and BloodSafe?
        • Managing blood at Burnside Hospital?
        • Review and change management
        • Improved outcomes
        • Meeting Standard 7
      • The Royal Children's Hospital Melbourne Extended Life Plasma Protocol Case Study
        • Implementing the ELP Protocol
        • The Laboratory Process
        • Post Implementation
      • Preoperative Anaemia Identification, Assessment and Management Case Study
      • Point of Care Coagulation Testing Case Study
      • Liverpool Hospital RFID Case Study
    • Stewardship
    • Patient Blood Management
      • PBM Guidelines
        • Module 1 Critical Bleeding/Massive Transfusion
        • Module 2 Perioperative
        • Module 3 Medical
        • Module 4 Critical Care
        • Module 5 Obstetrics and Maternity
        • Module 6 Neonatal and Paediatrics
        • PBM Guidelines Progress Updates
        • PBM Guidelines Launch
      • Implementing Patient Blood Management
      • Supporting Patients in PBM Decision Making
    • Immunoglobulin (Ig)
      • National Immunoglobulin Governance Program
      • National Policy: Immunoglobulin
      • National Immunoglobulin Governance Committees
      • National Immunoglobulin Governance Program Performance Improvement Strategy 2019-2022
      • Criteria for the Clinical Use of Immunoglobulin in Australia
        • Criteria Updates
      • Version 3 of the Criteria! (page under review)
        • Version 3 Criteria Newsletter (page under review)
      • Ig Program Updates
      • Ig usage data and statistics
      • Access to Intravenous Immunoglobulin (IVIg)
      • Access to Subcutaneous Immunoglobulin (SCIg)
        • Access to Subcutaneous immunoglobulin (SCIg) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • Ig Access Outside of the National Blood Arrangements
      • Access to Normal Human Immunoglobulin (NHIg)
      • BloodSTAR
      • BloodSTAR Privacy Controls
      • Ig Resources – for patients and health professionals
      • Review of the Authorisation and Clinical Governance Framework for Intravenous Immunoglobulin (2012)
      • Ig HTA Reviews
    • Prophylactic use of Rh D immunoglobulin in maternity care
      • Testing of maternal blood to determine fetal RHD genotype
    • Fresh Blood Products
      • Platelets
      • Cytomegalovirus (CMV) Seronegative Blood Products
    • Bleeding Disorders
      • Guidelines for the management of haemophilia in Australia
    • Education and Training
    • Haemovigilance
      • Adverse Events
        • Where do I Report Adverse Events
      • Case Studies
    • NBA sponsored awards
  • Blood Systems
    • Overview: Blood Systems
    • Blood Operations Centre
    • Australian Bleeding Disorders Registry
      • Privacy of patient information in ABDR and MyABDR
    • Big Red
    • BloodNet
      • BloodNet Laboratory Information System (LIS) Interfaces
        • BloodNet Specifications for Interfacing
        • Certified Interfaces
        • Vendor Certification Process
        • Facility Certification Process
        • LIS-BloodNet-BloodSTAR Integration
      • BloodNet News
      • BloodNet Support Materials
    • BloodPortal
    • Jurisdictional Reporting
    • MyABDR
      • Privacy of patient information in ABDR and MyABDR
    • Barcode Specifications
    • BloodSTAR
      • BloodSTAR Support Materials
        • Prescriber / Nurse Practitioner
          • Creating an authorisation request
        • Nurse / Midwife / Admin Support
        • Dispenser
        • Facility Administrator
      • BloodSTAR calculator for adjusting Ig dose for ideal body weight
      • BloodSTAR Facility Registration
      • Who will access BloodSTAR?
      • BloodSTAR Privacy Controls
  • Data & Research
    • Overview: Data & Research
    • Data Analysis and Reporting
    • Data Governance
    • Sector Monitoring
    • Sector Performance Indicators
    • Haemovigilance Reporting
    • Red Cell Usage
    • Research and Development
      • Results of Round 1
      • Results of Round 2
      • Results of Round 3
      • Results of Round 4
      • Results of Round 5
      • Completed Grants from the National Blood Sector Research and Development Program
    • Blood Measures and Data Linkage
  • About Blood
    • Overview: About Blood
    • Fresh Blood Products
    • Plasma and Recombinant Products
    • Safety of Blood Products
  • Publications & Tools
    • Overview: Publications & Tools
    • Search Publications and Tools
    • Publication Order Form
    • Open Public Consultations
    • Closed Public Consultations
    • National Immunohaematology Continuing Education (NICE) Proceedings

You are here

Home » Ensuring Supply » Blood Product Managment » Managing Blood and Blood Product Inventory Guidelines for Australian Health Providers » Module 2: Ig Inventory Management Guidelines

Module 2: Ig Inventory Management Guidelines

Module 2 Ig Inventory Management Guidelines (pdf) (1.85 MB)

Module 2 Ig Inventory Management Guidelines (docx) (1.17 MB)

  • Introduction
  • Role of the Dispenser
  • Keeping Appropriate Inventory Levels
  • Ordering
  • Dispensing
  • References
  • Overview: Ensuring Supply
  • What Blood Products are Supplied - National Product Price List
  • Supply Planning and Management
  • Changes to National Product Price List
  • Contracts with Suppliers
  • Supply to Australians Overseas
  • Risk Management
  • Blood Product Managment
    • Wastage
    • 10 Tips to Help Manage your Blood Product Inventory
    • Group O negative red blood cell management
    • Managing Blood and Blood Product Inventory Guidelines for Australian Health Providers
      • Module 1: Managing Blood and Blood Product Transfers
      • Module 2: Ig Inventory Management Guidelines
  • Transition of Australia's Domestic Plasma Products: What you need to do to start preparing
  • Australian Health Provider Blood and Blood Products Charter
Patient Blood Management Guidelines

donate blood

  • About NBA
  • For Health Professionals
  • For Patients

Key links

  • About NBA
  • News
  • Employment
  • Home
  • Contact Us
  • Feedback

Our work

  • Ensuring supply
  • Best practice
  • Blood systems
  • Data and research
  • About NBA
  • Publications & Tools

Site information

  • Accessibility
  • Copyright
  • Disclaimer
  • Privacy
  • Public Interest Disclosure

Share this page

  • PrintPrint
  • Email this pageEmail this page
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn

donate blood

  • About NBA
  • For Health Professionals
  • For Patients

©

Commonwealth of Australia